Investor Relations
CORPORATE PROFILE
Nuvectra® is a neurostimulation company committed to helping physicians improve
the lives of people with chronic conditions. The Algovita® Spinal Cord
Stimulation (SCS) System is our first commercial offering and is CE marked and
FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our
innovative technology platform also has capabilities under development to
support other neurological indications such as sacral nerve stimulation (SNS),
and deep brain stimulation (DBS).
On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas with additional locations in Denver and Minneapolis.
Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."
On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas with additional locations in Denver and Minneapolis.
Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."

STOCK QUOTE
(Common Stock)
|
Copyright West LLC. Minimum 15 minutes delayed.
STOCK CHART
INVESTOR CONTACT
The Ruth Group
Tram Bui
investors@nuvectramed.com